ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Emvision Medical Devices (EMV.AU)
Emvision Medical Devices share price today, ATLAS forecast and fair value
Healthcare · Medical Devices · Australian Securities Exchange · Australia
A$1.55▲ +1.31%
Prices as of Oct 27, 2026 · AUD
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Emvision Medical Devices in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Emvision Medical Devices
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Emvision Medical Devices a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between A$1.42 and A$1.67; in 9 out of 10, between A$1.24 and A$1.92. Estimated annual volatility is 45%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- A$150M
- Market cap (USD)
- $106M
- 52-week high
- A$1.96
- 52-week low
- A$1.46
- Revenue (12 months)
- A$8.4M
- Operating margin
- -100.8%
- Net margin
- -99.5%
- Beta
- 1.10
What this means
ATLAS does not publish a fair value for EMV.AU right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks EMV.AU has traded between A$1.46 and A$1.96. Today it is 21.0% below that high and 6% above its low.
Its beta is 1.10: it moves roughly in line with the market.
About the company
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia.
Want to see everything about Emvision Medical Devices?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Emvision Medical Devices do?
EMVision Medical Devices Ltd engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia.
What is the chance EMV.AU goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, EMV.AU ends the month between A$1.42 and A$1.67.
How big is Emvision Medical Devices and what is its P/E ratio?
Emvision Medical Devices's market capitalization is A$150M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is EMV.AU?
ATLAS estimates annual volatility at 45%. In a typical month, half of the outcomes end between A$1.42 and A$1.67.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer